Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

被引：156
|
作者：
Targher, Giovanni [1 ]
Mantovani, Alessandro [1 ]
Byrne, Christopher D. [2 ]
Wang, Xiao-Bo [3 ]
Yan, Hua-Dong [4 ]
Sun, Qing-Feng [5 ]
Pan, Ke-Hua [5 ]
Zheng, Kenneth I. [6 ]
Chen, Yong-Ping [7 ]
Eslam, Mohammed [8 ]
George, Jacob [8 ]
Zheng, Ming-Hua [6 ,9 ]
机构：
[1] Univ Verona, Dept Med Endocrinol & Metab, I-37126 Verona, Veneto, Italy
[2] Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, Hants, England
[3] Wenzhou Med Coll, Dept Crit Care Med, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Ningbo 2 Hosp, Dept Hepatol, Ningbo, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China
[6] Wenzhou Med Coll, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Zhejiang, Peoples R China
[7] Wenzhou Med Coll, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou, Zhejiang, Peoples R China
[8] Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia
[9] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Zhejiang, Peoples R China
来源：
GUT | 2020年 / 69卷 / 08期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1136/gutjnl-2020-321611
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1545 / +
页数：3
相关论文
共 50 条
  • [1] Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease A Meta-analysis
    Tao, Ziwen
    Li, Yueyue
    Cheng, Baoquan
    Zhou, Tao
    Gao, Yanjing
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (10) : 830 - 835
  • [2] Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
    Sharma, Praveen
    Kumar, Ashish
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 825 - 827
  • [3] Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores
    Yao, Renling
    Zhu, Li
    Wang, Jian
    Liu, Jiacheng
    Xue, Ruifei
    Xue, Leyang
    Liu, Longgen
    Li, Chunyang
    Zhao, Haiyan
    Cheng, Juan
    Huang, Songping
    Li, Yang
    Zhao, Xiang-an
    Zhu, Chuanwu
    Li, Ming
    Huang, Rui
    Wu, Chao
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (08)
  • [4] Risk Factors for Advanced Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sachar, Moniyka
    Pan, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S561 - S561
  • [5] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Fan, Hong
    Li, Lili
    Liu, Zhenqiu
    Zhang, Pengyan
    Wu, Sheng
    Han, Xinyu
    Chen, Xingdong
    Suo, Chen
    Cao, Liou
    Zhang, Tiejun
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [6] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Fan
    Lili Li
    Zhenqiu Liu
    Pengyan Zhang
    Sheng Wu
    Xinyu Han
    Xingdong Chen
    Chen Suo
    Liou Cao
    Tiejun Zhang
    BMC Gastroenterology, 23
  • [7] CORRELATION BETWEEN COVID-19 SEVERITY AND NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
    Tungtrongchitr, Nuttapat
    Srivanitchapoom, Nantaporn
    Hirunpat, Pornrujee
    Sungkanuparph, Somnuek
    GASTROENTEROLOGY, 2023, 164 (06) : S1394 - S1395
  • [8] Risk scores for metabolic dysfunction-associated fatty liver disease in pediatric obesity
    Lischka, Julia
    Lieb, Katharina
    Schanzer, Andrea
    Hojreh, Azadeh
    Ba-Ssalamah, Ahmed
    de Gier, Charlotte
    Walleczek, Nina-Katharina
    Zeyda, Maximilian
    Greber-Platzer, Susanne
    ANNALS OF NUTRITION AND METABOLISM, 2022, 78 (05) : 247 - 254
  • [9] Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Lu, Chuan
    Chen, Yan
    Zhang, Yue
    Zhao, Xin
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2627 - 2637
  • [10] Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
    Aydin, Murat
    Aksakal, Berrin
    Basat, Sema
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 357 - 363
12345